SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-004277
Filing Date
2005-07-29
Accepted
2005-07-29 12:58:04
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b55584oie10vq.htm 10-Q 155482
2 EX-10.1 LEASE MODIFICATION AGREEMENT NO.1 b55584oiexv10w1.htm EX-10.1 50092
3 EX-10.2 DESCRIPTION OF DIRECTOR COMPENSATION ARRANGEMENTS b55584oiexv10w2.htm EX-10.2 1718
4 EX-10.3 DESCRIPTION OF NAMED EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS b55584oiexv10w3.htm EX-10.3 3932
5 EX-31.1 SEC. 302 CEO CERTIFICATION b55584oiexv31w1.htm EX-31.1 6613
6 EX-31.2 SEC. 302 CFO CERTIFICATION b55584oiexv31w2.htm EX-31.2 6633
7 EX-32.1 SEC. 906 CEO AND CFO CERTIFICATION b55584oiexv32w1.htm EX-32.1 5176
8 GRAPHIC b55584oib5558400.gif GRAPHIC 64077
  Complete submission text file 0000950135-05-004277.txt   319374
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 05983754
SIC: 2836 Biological Products, (No Diagnostic Substances)